The Tripoli based Libyan Ministry of Health reported (yesterday / Tuesday 9 December) that the Undersecretary and Acting Minister of Health, Mohammed Al-Ghouj, and representatives from the Ministry of Economy, held a virtual meeting with several investors and private sector companies participating in the initiative to establish a pharmaceutical factory in Libya.
The Ministry said this comes as part of the Ministry of Health’s plan to localize the pharmaceutical industry and encourage investment in this vital sector.
During the meeting, the details of the initiative were reviewed, and the main partner, Azhar Saudi Arabia, was introduced.
Azhar is a leading institution in the fields of health development and investment, including the establishment of hospitals, medical universities, research centers, and pharmaceutical factories, in cooperation with a select group of specialized regional and international consulting firms.
The Acting Undersecretary confirmed that the Ministry has already begun preparing the necessary technical and procedural framework and updating regulatory requirements to facilitate the launch of the project. He emphasized the strict adherence to quality standards at all stages of implementation to ensure that the project becomes a genuine contributor to the national economy and helps achieve pharmaceutical security for the country.
The attendees agreed to hold subsequent meetings between the specialized technical teams from both sides, with the aim of moving the initiative to the practical implementation phase as soon as possible.
.
Ministries of Health and Industry discuss reactivation of Libya’s pharma industry at Rabta factory
The 200-unit Tripoli medicines and supplies complex unites main suppliers in one location
ESDF discusses localizing manufacture of anti-coronavirus vaccines to limit imports
